Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01545674 · ClinicalTrials.gov registry record
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
A clinical trial, sponsored by Natera.
- Terminated
- Registry status
- 937
- Enrollment target
NCT01545674 is a clinical trial that was terminated before completion, run by Natera. The registered enrollment target is 937 participants.
The verdict
NCT01545674 was terminated before completion, sponsored by Natera.
- TERMINATED
- Registry status
- 937 participants
- Enrollment target
Study Summary
This prospective blinded study will assess the diagnostic capability of an informatics enhanced SNP based technology (Parental Support) to identify pregnant women who are carrying a fetus with an aneuploidy from fee floating DNA in the maternal blood.
Interventions
- PROCEDURE Blood Draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 937 participants |
| Start Date | 2012-01 |
| Est. Completion | 2023-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01545674
The ClinicalTrials.gov registry entry for NCT01545674 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 937 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Draw is the first listed.
NCT01545674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01545674 about?
NCT01545674 is a clinical study titled "Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial". This prospective blinded study will assess the diagnostic capability of an informatics enhanced SNP based technology (Parental Support) to identify pregnant women who are carrying a fetus with an aneuploidy from fee floating DNA in the maternal blood.
What is the current status of trial NCT01545674?
This trial is currently terminated. The enrollment target is 937 participants. The study started on 2012-01. Estimated completion is 2023-03.
What interventions are being tested in trial NCT01545674?
The interventions under investigation include: Blood Draw (PROCEDURE).
Who is sponsoring clinical trial NCT01545674?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.